Both low and high 24-hour diastolic blood pressure are associated with worse cognitive performance in type 2 diabetes: The Maastricht study

Diabetes Care

Volumn 38, Issue 8, 2015, Pages 1473-1480

  Spauwen, Peggy J J ^a,b   Van Boxtel, Martin P J ^a,b   Verhey, Frans R J ^a,b   Köhler, Sebastian ^a,b   Sep, Simone J S ^a,c   Koster, Annemarie ^b   Dagnelie, Pieter C ^b,c   Henry, Ronald M A ^a,c   Schaper, Nicolaas C ^a,c   Van Der Kallen, Carla J H ^a,c   Schram, Miranda T ^a,c   Kroon, Abraham A ^a,c   Stehouwer, Coen D A ^a,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BRAIN FUNCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COGNITION; COGNITION ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DRUG USE; FEMALE; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; POPULATION RESEARCH; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; VERBAL MEMORY; AGED; BLOOD PRESSURE; COGNITION DISORDERS; DIASTOLE; EPIDEMIOLOGY; HYPERTENSION; MIDDLE AGED; NETHERLANDS; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SHORT TERM MEMORY;

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; DIASTOLE; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; HYPERTENSION; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NETHERLANDS;

EID: 84962359404     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-2502     Document Type: Article

References (52)

1. Spauwen PJ, Köhler S, Verhey FR, Stehouwer CD, van Boxtel MP. Effects of type 2 diabetes on 12-year cognitive change: results from theMaastricht Aging Study. Diabetes Care 2013;36:1554- 1561.
2. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol 2006;5:64-74.
3. van den Berg E, Dekker JM, Nijpels G, et al. Blood pressure levels in pre-diabetic stages are associated with worse cognitive functioning in patients with type 2 diabetes. Diabetes Metab Res Rev 2009;25:657-664.
4. Bruce DG, Davis WA, Casey GP, et al. Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia 2008;51: 241-248.
5. Hassing LB, Hofer SM, Nilsson SE, et al. Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 2004;33: 355-361.
6. Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project: A 6-year follow-up study. Neurology 2004;63:1181-1186.
7. Korf ES, van Straaten EC, de Leeuw FE, et al.; LADIS Study Group. Diabetes mellitus, hypertension and medial temporal lobe atrophy: The LADIS study. Diabet Med 2007;24:166-171.
8. Gregg EW, Yaffe K, Cauley JA, et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 2000;160:174-180.
9. White WB, Wolfson L, Wakefield DB, et al. Average daily blood pressure, not office blood pressure, is associated with progression of cerebrovascular disease and cognitive decline in older people. Circulation 2011;124:2312-2319.
10. Yano Y, Kario K. Nocturnal blood pressure, morning blood pressure surge, and cerebrovascular events. Curr Hypertens Rep 2012;14:219- 227.
11. van Boxtel MP, Gaillard C, Houx PJ, Buntinx F, de Leeuw PW, Jolles J. Is nondipping in 24 h ambulatory blood pressure related to cognitive dysfunction? J Hypertens 1998;16:1425-1432.
12. Okuno J, Yanagi H. Cognitive impairment and nocturnal blood pressure fall in treated elderly hypertensives. Environ Health Prev Med 2003;8:124-132.
13. Ayala DE, Moýa A, Crespo JJ, et al.; Hygia Project Investigators. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol Int 2013;30:99-115.
14. Waldstein SR, Giggey PP, Thayer JF, Zonderman AB. Nonlinear relations of blood pressure to cognitive function: The Baltimore Longitudinal Study of Aging. Hypertension 2005;45:374-379.
15. Taylor C, Tillin T, Chaturvedi N, et al. Midlife hypertensive status and cognitive function 20 years later: The Southall and Brent revisited study. J Am Geriatr Soc 2013;61:1489-1498.
16. Schram MT, Sep SJ, van der Kallen CJ, et al. The Maastricht Study: An extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities. Eur J Epidemiol 2014;29:439-451.
17. World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Geneva, World Health Org., 2006.
18. O'Brien E, Coats A, Owens P, et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society. BMJ 2000;320:1128-1134.
19. Muris DM, Houben AJ, Kroon AA, et al. Age, waist circumference, and blood pressure are associated with skin microvascular flow motion: The Maastricht Study. J Hypertens 2014;32: 2439-2449; discussion 2449.
20. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159-2219.
21. Meaney E, Alva F, Moguel R, Meaney A, Alva J, Webel R. Formula and nomogram for the sphygmomanometric calculation of the mean arterial pressure. Heart 2000;84:64.
22. Kario K, Shimada K, Pickering TG. Abnormal nocturnal blood pressure falls in elderly hypertension: clinical significance and determinants. J Cardiovasc Pharmacol 2003;41(Suppl. 1):S61-S66.
23. Folstein MF, Folstein SE, McHugh PR. "Minimental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
24. Van der Elst W, van Boxtel MP, van Breukelen GJ, Jolles J. Rey's verbal learning test: normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and mode of presentation. J Int Neuropsychol Soc 2005;11:290-302.
25. Stroop JR. Studies of interference in serial verbal reaction. J Exp Psychol 1935;18:643-662.
26. Van der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J. The Stroop color-word test: influence of age, sex, and education; and normative data for a large sample across the adult age range. Assessment 2006;13:62-79.
27. van der Elst W, van Boxtel MP, van Breukelen GJ, Jolles J. The Letter Digit Substitution Test: normative data for 1, 858 healthy participants aged 24-81 from the Maastricht Aging Study (MAAS): influence of age, education, and sex. J Clin Exp Neuropsychol 2006;28:998-1009.
28. Spauwen PJ, van Eupen MG, Köhler S, et al. Associations of advanced glycation end-products with cognitive functions in individuals with and without type 2 diabetes: The Maastricht study. J Clin Endocrinol Metab 2015;100:951-960.
29. Levey AS, Stevens LA, Schmid CH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-612.
30. De Bie SE. Standard Questions 1987: Proposal for Uniformization of Questions Regarding Background Variables and Interviews. Leiden, the Netherlands, Leiden University Press, 1987 [in Dutch].
31. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59 (Suppl. 20):22-33; quiz 34-57.
32. Bilo G, Giglio A, Styczkiewicz K, et al. A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J Hypertens 2007;25:2058-2066.
33. den Heijer T, Launer LJ, Prins ND, et al. Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology 2005;64:263-267.
34. Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: A pathway to cardiovascular disease. Diabetologia 2008;51:527-539.
35. Witteman JC, Grobbee DE, Valkenburg HA, et al. J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet 1994;343:504-507.
36. CreagerMA, Lüscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation 2003;108:1527-1532.
37. Lassen NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev 1959;39:183-238.
38. Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev 1990;2:161-192.
39. KimYS, Immink RV, Stok WJ, Karemaker JM, Secher NH, van Lieshout JJ. Dynamic cerebral autoregulatory capacity is affected early in type 2 diabetes. Clin Sci (Lond) 2008;115:255- 262.
40. Marthol H, Brown CM, Zikeli U, et al. Altered cerebral regulation in type 2 diabetic patients with cardiac autonomic neuropathy. Diabetologia 2006;49:2481-2487.
41. Cipolla MJ. Control of cerebral blood flow. In Cerebral Circulation. San Rafael, CA, Morgan & Claypool Life Science, 2009.
42. Low PA, Benrud-Larson LM, Sletten DM, et al. Autonomic symptoms and diabetic neuropathy: A population-based study. Diabetes Care 2004;27:2942-2947.
43. Mehrabian S, Duron E, Labouree F, et al. Relationship between orthostatic hypotension and cognitive impairment in the elderly. J Neurol Sci 2010;299:45-48.
44. Umegaki H, Iimuro S, Shinozaki T, et al.; Japanese Elderly Diabetes Intervention Trial Study Group. Risk factors associated with cognitive decline in the elderly with type 2 diabetes: pooled logistic analysis of a 6-year observation in the Japanese Elderly Diabetes Intervention Trial. Geriatr Gerontol Int 2012;12(Suppl. 1): 110-116.
45. Akisaki T, Sakurai T, Takata T, et al. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab Res Rev 2006;22:376-384.
46. Schmidt R, Schmidt H, Kapeller P, Lechner A, Fazekas F. Evolution of white matter lesions. Cerebrovasc Dis 2002;13(Suppl. 2):16-20.
47. van Boxtel MP, Henskens LH, Kroon AA, et al. Ambulatory blood pressure, asymptomatic cerebrovascular damage and cognitive function in essential hypertension. J Hum Hypertens 2006;20:5-13.
48. Sierra C, de La Sierra A, Mercader J, Gómez- Angelats E, Urbano-Marquez A, Coca A. Silent cerebral white matter lesions in middle-aged essential hypertensive patients. J Hypertens 2002;20:519-524.
49. Cuspidi C, Macca G, Michev I, et al. Shortterm reproducibility of nocturnal non-dipping pattern in recently diagnosed essential hypertensives. Blood Press 2002;11:79-83.
50. Parati G, Ochoa JE, Salvi P, Lombardi C, Bilo G. Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes. Diabetes Care 2013;36(Suppl. 2):S312-S324.
51. Kilander L, Nyman H, Boberg M, Hansson L, Lithell H. Hypertension is related to cognitive impairment: A 20-year follow-up of 999 men. Hypertension 1998;31:780-786.
52. Köhler S, BaarsMA, Spauwen P, Schievink S, Verhey FR, van Boxtel MJ. Temporal evolution of cognitive changes in incident hypertension: prospective cohort study across the adult age span. Hypertension 2014;63:.